Congenital Nephrogenic Diabetes Insipidus

Congenital nephrogenic diabetes insipidus is a rare inherited disorder where the kidneys cannot respond properly to a natural hormone, causing the body to produce large amounts of dilute urine and leading to excessive thirst and the risk of severe dehydration.

Table of contents

• What is congenital nephrogenic diabetes insipidus?
• Causes and genetic patterns
• Signs and symptoms
• Diagnosis and testing
• Treatment and management
• Possible complications
• Outlook and long-term care

What is congenital nephrogenic diabetes insipidus?

Congenital nephrogenic diabetes insipidus is a rare inherited disorder of water balance in the body. It occurs when the kidneys cannot properly respond to a hormone called antidiuretic hormone (ADH), also known as arginine vasopressin (AVP). This hormone normally tells the kidneys how much water to keep in the body and how much to release as urine^[1][2].

In healthy people, ADH helps the kidneys concentrate urine by reducing the amount of water lost from the body. When someone has congenital nephrogenic diabetes insipidus, the kidneys lose their ability to respond to this hormone signal. As a result, the body produces very large amounts of dilute, watery urine^[1][5].

The condition is present from birth and affects how the body maintains proper fluid balance. The word “nephrogenic” means the problem originates in the kidneys, and “diabetes insipidus” refers to the production of large volumes of tasteless urine, which is different from diabetes mellitus where high blood sugar causes increased urination^[5][10].

Causes and genetic patterns

Congenital nephrogenic diabetes insipidus is caused by mutations in genes that provide instructions for responding to ADH. In approximately 90% of cases, the condition results from mutations in the AVPR2 gene, which provides instructions for making the vasopressin V2 receptor. This form is inherited in an X-linked pattern, meaning it primarily affects males. Females who carry one copy of the mutated gene may have mild symptoms or no symptoms at all^[1][3].

In approximately 10% of cases, the condition is caused by mutations in the AQP2 gene, which provides instructions for making aquaporin-2 water channels. This form can be inherited in either an autosomal recessive pattern (requiring two mutated copies, one from each parent) or, more rarely, an autosomal dominant pattern (requiring only one mutated copy)^[1][3].

The AVPR2 gene is located on the X chromosome, which explains why males are more commonly and severely affected. Males have only one X chromosome, so a single mutated copy of the gene causes the condition. Females have two X chromosomes, so they typically need mutations in both copies to be fully affected, though some females with one mutated copy may show partial symptoms^[3][10].

Signs and symptoms

The signs and symptoms of congenital nephrogenic diabetes insipidus usually appear within the first few months of life. The most prominent features include polyuria (excessive urine production) and polydipsia (excessive thirst). Affected infants may produce more than 4 milliliters of urine per kilogram of body weight per hour, which is significantly more than normal^[1][3].

In infants, symptoms may include poor feeding, irritability, failure to gain weight or grow properly, and unexplained fevers. Babies may cry excessively and prefer water over milk. They may also experience frequent episodes of vomiting and constipation due to dehydration^[3][7].

Untreated infants commonly develop severe dehydration with elevated sodium levels in the blood, a condition called hypernatremia. This can occur rapidly, especially during illness, hot weather, or when water intake is limited. Signs of dehydration include dry mouth, sunken eyes, sunken soft spots (fontanelles) in infants, dry skin, fatigue, rapid heart rate, and low body temperature^[5][7].

Older children and adults with the condition experience intense thirst and may need to urinate every hour, including throughout the night. They may crave ice water specifically and drink from unusual sources to satisfy their thirst. Some affected individuals may need to wake frequently during the night to drink and urinate^[1][10].

Diagnosis and testing

Diagnosing congenital nephrogenic diabetes insipidus involves several types of tests. The initial evaluation typically includes measuring urine output, checking the concentration of urine and blood, and testing blood sodium levels. In affected individuals, urine is very dilute with low specific gravity (less than 1.010) and low osmolality (less than 300 mOsm/kg), while blood shows high sodium levels (greater than 145 mEq/L) and high osmolality (greater than 300 mOsm/kg)^[2][7].

A key diagnostic test is measuring paired early morning urine and serum osmolality. In nephrogenic diabetes insipidus, the serum osmolality is high while the urine remains inappropriately dilute, showing that the kidneys are not responding properly to ADH^[19].

A water deprivation test may be performed under careful medical supervision. During this test, fluid intake is stopped for several hours while body weight, urine output, and the concentration of urine and blood are measured. The test may also include giving a manufactured form of ADH to see if the kidneys can respond. In nephrogenic diabetes insipidus, the kidneys fail to concentrate urine even after ADH is given^[16].

Genetic testing is essential for confirming the diagnosis. For males with suspected nephrogenic diabetes insipidus, testing identifies a hemizygous pathogenic variant in AVPR2 or compound heterozygous or homozygous pathogenic variants in AQP2. For females, testing typically identifies heterozygous pathogenic variants in AVPR2 or compound heterozygous or homozygous pathogenic variants in AQP2^[1].

Additional tests may include kidney ultrasound to check for complications such as dilated ureters or bladder, and measurement of other electrolytes including potassium and calcium^[7].

Treatment and management

Treatment of congenital nephrogenic diabetes insipidus focuses on maintaining proper fluid balance and preventing dehydration. The cornerstone of management is ensuring free and unlimited access to drinking water and toilet facilities at all times. Water intake must never be restricted, as affected individuals depend on their thirst response to maintain safe sodium levels^[1][2].

For infants, ensuring adequate water intake can be challenging. Parents may need to provide additional water between milk feedings or use low-sodium, hypo-osmolar formulas designed to reduce the body’s need to produce large amounts of urine^[4][8].

Medication treatment can reduce urine output by up to 50% without causing elevated sodium levels. The most commonly used medication is hydrochlorothiazide, a thiazide diuretic that paradoxically reduces urine production in nephrogenic diabetes insipidus. This medication is often combined with either amiloride (a potassium-sparing diuretic) or a nonsteroidal anti-inflammatory drug such as indomethacin^[1][11].

The combination of hydrochlorothiazide with amiloride is preferred by many specialists because it reduces the risk of potassium loss and may have fewer side effects than indomethacin. Some patients respond well to hydrochlorothiazide with spironolactone, another potassium-sparing diuretic^[3][8].

Dietary management includes restricting sodium intake, as lower sodium reduces the amount of waste products the kidneys need to eliminate, thereby reducing urine output. This is particularly important in infants and young children^[1][8].

During periods when oral intake is not possible (such as during surgery or illness), affected individuals require intravenous replacement of their usual oral water intake using 5% dextrose in water. Normal saline (0.9% sodium chloride) should not be used as it can worsen hypernatremia^[1].

Regular monitoring is essential. Infants should have their growth and development checked at least every three months, with serum sodium measured to identify early dehydration. Older children should be monitored at least every six months. Annual kidney ultrasound examinations help detect complications such as dilated ureters or bladder^[1][2].

Possible complications

Without proper treatment, congenital nephrogenic diabetes insipidus can cause serious complications. Repeated episodes of dehydration with elevated sodium levels can lead to irreversible brain damage, developmental delays, and intellectual disability. This is particularly concerning in young children whose brains are still developing^[3][7].

The chronic production of large volumes of urine can cause structural changes in the urinary system. These include hydronephrosis (swelling of the kidneys), hydroureter (swelling of the tubes that carry urine from the kidneys to the bladder), and megacystis (an abnormally enlarged bladder). These complications result from the constant high volume of urine production and may require medical or surgical intervention^[1][7].

Growth failure and short stature are common in untreated individuals, as the body’s preference for water over food can lead to inadequate nutrition. However, early diagnosis and appropriate treatment can allow for catch-up growth^[1][8].

Behavioral problems may develop, particularly related to the constant need to access water and bathrooms. Children may experience anxiety about being away from water sources or difficulty participating in normal activities^[8].

In severe cases of untreated dehydration, complications can include shock, seizures, coma, and potentially death. This underscores the importance of early diagnosis and proper management^[5][7].

Outlook and long-term care

With proper management, individuals with congenital nephrogenic diabetes insipidus can lead relatively normal lives. The key to a good outcome is early diagnosis, consistent access to water, appropriate medication, and regular medical monitoring. Treatment must continue throughout life, as this is a permanent condition^[1][5].

Care should be managed by a multidisciplinary team that may include pediatric nephrologists, endocrinologists, nutritionists, and clinical geneticists. This team approach helps address the various aspects of the condition and ensures comprehensive care^[1][2].

Families should be educated about the importance of never restricting water access, recognizing signs of dehydration, and managing the condition during illness or other stressful situations. Parents and caregivers need to inform schools and other caregivers about the child’s need for unlimited access to water and bathrooms^[2].

Genetic counseling is recommended for affected families to understand inheritance patterns and recurrence risks for future pregnancies. Family members may need to be tested to identify carriers of the genetic mutations^[1][2].

Regular follow-up care is essential throughout life to monitor growth in children, check for complications, adjust medications as needed, and ensure that sodium levels remain in a safe range. With proper care and attention, many individuals with congenital nephrogenic diabetes insipidus can achieve normal growth and development and maintain good quality of life^[7][8].